Your browser doesn't support javascript.
loading
The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis.
Prince, Amanda L; Ma, Jun; Kannan, Paranthaman S; Alvarez, Manuel; Gisslen, Tate; Harris, R Alan; Sweeney, Emma L; Knox, Christine L; Lambers, Donna S; Jobe, Alan H; Chougnet, Claire A; Kallapur, Suhas G; Aagaard, Kjersti M.
Afiliação
  • Prince AL; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Ma J; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Kannan PS; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Alvarez M; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Gisslen T; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Harris RA; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Sweeney EL; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Knox CL; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Lambers DS; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Jobe AH; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Chougnet CA; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Kallapur SG; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
  • Aagaard KM; Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine,
Am J Obstet Gynecol ; 214(5): 627.e1-627.e16, 2016 05.
Article em En | MEDLINE | ID: mdl-26965447
ABSTRACT

BACKGROUND:

Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality and is not uncommonly associated with chorioamnionitis. We recently have demonstrated that the placenta harbors a unique microbiome with similar flora to the oral community. We also have shown an association of these placental microbiota with PTB, history of antenatal infection, and excess maternal weight gain. On the basis of these previous observations, we hypothesized that the placental membranes would retain a microbiome community that would vary in association with preterm birth and chorioamnionitis.

OBJECTIVE:

In the current study, we aimed to examine the differences in the placental membrane microbiome in association with PTB in both the presence and absence of chorioamnionitis and/or funisitis using state-of-the-science whole-genome shotgun metagenomics. STUDY

DESIGN:

This was a cross-sectional analysis with 6 nested spontaneous birth cohorts (n = 9-15 subjects/cohort) Term gestations without chorioamnionitis, term with chorioamnionitis, preterm without chorioamnionitis, preterm with mild chorioamnionitis, preterm with severe chorioamnionitis, and preterm with chorioamnionitis and funisitis. Histologic analysis was performed with Redline's criteria, and inflammatory cytokines were analyzed in the cord blood. DNA from placental membranes was extracted from sterile swabs collected at delivery, and whole-genome shotgun sequencing was performed on the Illumina HiSeq platform. Filtered microbial DNA sequences were annotated and analyzed with MG-RAST (ie, Metagenomic Rapid Annotations using Subsystems Technology) and R.

RESULTS:

Subjects were assigned to cohorts on the basis of gestational age at delivery and independent scoring of histologic chorioamnionitis. We found that preterm subjects with severe chorioamnionitis and funisitis had increases in cord blood inflammatory cytokines. Of interest, although the placental membrane microbiome was altered in association with severity of histologic chorioamnionitis (permutational multivariate analysis of variance P = .005), there was no observable impact with either betamethasone or antibiotic treatment. In preterm subjects with chorioamnionitis, we found a high abundance of both urogenital and oral commensal bacteria. These alterations in the microbiome were accompanied by significant variation (P < .05) in microbial metabolic pathways important in the glucose-fed pentose phosphate pathway (term subjects), or glycerophopholipid metabolism, and the biosynthesis of the siderophore group nonribosomal peptides (preterm subjects).

CONCLUSION:

Consistent with ours and others previous findings, women who experienced spontaneous PTB harbor placental microbiota that further differed by severity of chorioamnionitis. Integrative metagenomic analysis revealed significant variation in distinct bacterial metabolic pathways, which we speculate may contribute to risk of preterm birth with and without severe chorioamnionitis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta / Corioamnionite / Nascimento Prematuro / Microbiota Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta / Corioamnionite / Nascimento Prematuro / Microbiota Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2016 Tipo de documento: Article